Cargando…

Innate stimulation of B cells ex vivo enhances antibody secretion and identifies tumour-reactive antibodies from cancer patients

Human B cells and their expressed antibodies are crucial in conferring immune protection. Identifying pathogen-specific antibodies following infection is possible due to enhanced humoral immunity against well-described molecules on the pathogen surface. However, screening for cancer-reactive antibod...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karagiannis, Panagiotis, Correa, Isabel, Chauhan, Jitesh, Cheung, Anthony, Dominguez-Rodriguez, Diana, Terranova-Barberio, Manuela, Harris, Robert J, Crescioli, Silvia, Spicer, James, Bokemeyer, Carsten, Lacy, Katie E, Karagiannis, Sophia N
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802180/ https://www.ncbi.nlm.nih.gov/pubmed/35020866 http://dx.doi.org/10.1093/cei/uxab005

Ejemplares similares

Antibody therapies for melanoma: New and emerging opportunities to activate immunity (Review)
por: MALAS, SADEK, et al.
Publicado: (2014)

In vivo trafficking of a tumor-targeting IgE antibody: molecular imaging demonstrates rapid hepatobiliary clearance compared to IgG counterpart
por: Man, Francis, et al.
Publicado: (2021)

Chondroitin Sulfate Proteoglycan 4 and Its Potential As an Antibody Immunotherapy Target across Different Tumor Types
por: Ilieva, Kristina M., et al.
Publicado: (2018)

Evaluation of Antigen-Conjugated Fluorescent Beads to Identify Antigen-Specific B Cells
por: Correa, Isabel, et al.
Publicado: (2018)

Special Issue “Antibody Engineering for Cancer Immunotherapy”
por: Crescioli, Silvia, et al.
Publicado: (2022)

B Cells in Patients With Melanoma: Implications for Treatment With Checkpoint Inhibitor Antibodies
por: Willsmore, Zena N., et al.
Publicado: (2021)

IgE Antibodies against Cancer: Efficacy and Safety
por: Chauhan, Jitesh, et al.
Publicado: (2020)

Antibody structure and engineering considerations for the design and function of Antibody Drug Conjugates (ADCs)
por: Hoffmann, Ricarda M., et al.
Publicado: (2017)

A Novel Antibody-Drug Conjugate (ADC) Delivering a DNA Mono-Alkylating Payload to Chondroitin Sulfate Proteoglycan (CSPG4)-Expressing Melanoma
por: Hoffmann, Ricarda M., et al.
Publicado: (2020)

B cell profiles, antibody repertoire and reactivity reveal dysregulated responses with autoimmune features in melanoma
por: Crescioli, Silvia, et al.
Publicado: (2023)

Enriched circulating and tumor-resident TGF-β(+) regulatory B cells in patients with melanoma promote FOXP3(+) Tregs
por: Harris, Robert J, et al.
Publicado: (2022)

IgG4 antibodies and cancer-associated inflammation: Insights into a novel mechanism of immune escape
por: Karagiannis, Panagiotis, et al.
Publicado: (2013)

Rapid conjugation of antibodies to toxins to select candidates for the development of anticancer Antibody-Drug Conjugates (ADCs)
por: Hoffmann, Ricarda M., et al.
Publicado: (2020)

Clinical and Translational Significance of Basophils in Patients with Cancer
por: Chauhan, Jitesh, et al.
Publicado: (2022)

Macrophages in ovarian cancer and their interactions with monoclonal antibody therapies
por: Osborn, Gabriel, et al.
Publicado: (2021)

Functionally Active Fc Mutant Antibodies Recognizing Cancer Antigens Generated Rapidly at High Yields
por: Ilieva, Kristina M., et al.
Publicado: (2017)

Immune cell–antibody interactions in health and disease
por: Karagiannis, Sophia N, et al.
Publicado: (2022)

Therapeutic targets and new directions for antibodies developed for ovarian cancer
por: Bax, Heather J., et al.
Publicado: (2016)

Monitoring the Systemic Human Memory B Cell Compartment of Melanoma Patients for Anti-Tumor IgG Antibodies
por: Gilbert, Amy E., et al.
Publicado: (2011)

IgG4 Characteristics and Functions in Cancer Immunity
por: Crescioli, Silvia, et al.
Publicado: (2016)

Antibodies as biomarkers for cancer risk: a systematic review
por: Monroy-Iglesias, Maria J, et al.
Publicado: (2022)

Anti-cancer pro-inflammatory effects of an IgE antibody targeting the melanoma-associated antigen chondroitin sulfate proteoglycan 4
por: Chauhan, Jitesh, et al.
Publicado: (2023)

Standardized Supportive Care Documentation Improves Safety of High‐Dose Methotrexate Treatment
por: Alsdorf, Winfried H., et al.
Publicado: (2020)

Chemokine Pathways in Cutaneous Melanoma: Their Modulation by Cancer and Exploitation by the Clinician
por: Adams, Rebecca, et al.
Publicado: (2021)

B cells and the humoral response in melanoma: The overlooked players of the tumor microenvironment
por: Chiaruttini, Giulia, et al.
Publicado: (2017)

In Planta Glycan Engineering and Functional Activities of IgE Antibodies
por: Montero-Morales, Laura, et al.
Publicado: (2019)

A tool kit for rapid cloning and expression of recombinant antibodies
por: Dodev, Tihomir S., et al.
Publicado: (2014)

Evaluating Biomarkers in Melanoma
por: Karagiannis, Panagiotis, et al.
Publicado: (2015)

Target Antigen Attributes and Their Contributions to Clinically Approved Antibody-Drug Conjugates (ADCs) in Haematopoietic and Solid Cancers
por: Esapa, Benjamina, et al.
Publicado: (2023)

Antiviral antibody responses to systemic administration of an oncolytic RNA virus: the impact of standard concomitant anticancer chemotherapies
por: Roulstone, Victoria, et al.
Publicado: (2021)

Influencing tumor-associated macrophages in malignant melanoma with monoclonal antibodies
por: Adams, Rebecca, et al.
Publicado: (2022)

IgE Antibodies: From Structure to Function and Clinical Translation
por: Sutton, Brian J., et al.
Publicado: (2019)

Manipulating megakaryocytes to manufacture platelets ex vivo
por: Karagiannis, P, et al.
Publicado: (2015)

In vivo safety profile of a CSPG4-directed IgE antibody in an immunocompetent rat model
por: Williams, Iwan P., et al.
Publicado: (2019)

Insights from IgE Immune Surveillance in Allergy and Cancer for Anti-Tumour IgE Treatments
por: McCraw, Alex J., et al.
Publicado: (2021)

IgG subclass switching and clonal expansion in cutaneous melanoma and normal skin
por: Saul, Louise, et al.
Publicado: (2016)

Glycoengineering of Therapeutic Antibodies with Small Molecule Inhibitors
por: Li, Shasha, et al.
Publicado: (2021)

AllergoOncology: Expression platform development and functional profiling of an anti‐HER2 IgE antibody
por: Ilieva, Kristina M., et al.
Publicado: (2019)

IgE Activates Monocytes from Cancer Patients to Acquire a Pro-Inflammatory Phenotype
por: Nakamura, Mano, et al.
Publicado: (2020)

Elevated IgG4 in patient circulation is associated with the risk of disease progression in melanoma
por: Karagiannis, Panagiotis, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_1ljbkufca91hu3uin06j31t88n